Article Details

Merck to buy Acceleron for about $11.5 billion in rare-disease drugs push - CNBC

Retrieved on: 2021-09-30 10:55:14

Tags for this article:

Click the tags to see associated articles and topics

Merck to buy Acceleron for about $11.5 billion in rare-disease drugs push - CNBC. View article details on hiswai:

Excerpt

Merck will pay $180 per Acceleron share in cash, representing a premium of about 2.6% to the stock's closing price on Wednesday, according to Refinitiv data ...

Article found on: www.cnbc.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up